Instituto Dermatologico y Cirugia de Piel   Report issue

Academic/Hospital Phase 2
Founded: Santo Domingo Dominican Republic (1963)

Organization Overview

First Clinical Trial
2019
NCT04152226
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Instituto Dermatologico y Cirugia de Piel

Active Ingredients

Drugs in Phase 2 Trials (2)

dbi-001 (1 trial)

Janthinobacterium lividum (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dermatitis (Phase 2)

Dermatitis, Atopic (Phase 2)

Eczema (Phase 2)

Tinea (Phase 2)

Tinea Pedis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 2